drugset / Trial / NCT02291367
Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fasting Condition
RandomizedCrossoverOpen-labelTreatment
Summary
This study were to compare the relative bioavailability of Duloxetine HCl delayed release capsule 60 mg with that of 'CYMBALTA®' delayed release capsule 60 mg (Duloxetine HCl delayed release capsule 60 mg) in healthy, adult, human subjects under fasting conditions and to monitor safety of subjects
Timeline
- Start
- 2008-05
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Duloxetine | Small molecule | 60 mg | Oral |
Indications
No indication recorded.